Skip to main content
. 2018 Feb 27;16(2):e05182. doi: 10.2903/j.efsa.2018.5182

Figure 22.

Figure 22

Trends in resistance to ampicillin, ciprofloxacin/pefloxacin/nalidixic acid, cefotaxime and tetracycline in Salmonella Infantis from humans in 10 reporting countries, 2013–2016

  • Statistically significant increasing trends over 3–4 years, as tested by logistic regression (p ≤ 0.05), were observed for ciprofloxacin in Germany, for ampicillin in Germany and for tetracyclines in the Netherlands. Statistically significant decreasing trends over 3–4 years were observed for ampicillin in Slovakia and for cefotaxime in Belgium. Only countries testing at least 10 isolates per year were included in the analysis.